CarMax says tariff fears juiced used car demand in April
Driving the news: CarMax reported Friday that it sold 9% more used vehicles to retail customers in the most recent quarter than it did a year earlier, leading to a 7.5% rise in retail revenue.
Tariffs may have played a part. CEO William Nash noted a demand uptick correlated to tariff speculation, with April coming in as the strongest month in the company's quarter — but stressed the business was already growing before that.
Between the lines: Nash acknowledged that car shoppers are worried about price hikes and the resumption of federal student loan obligations. About 30% of the company's customers have student loans.
"But I don't think it's necessarily showed up so much in the buying habits at this point," he said in terms of pricing.
CarMax shares closed up 6.6% Friday on the report.
Zoom out: Industrywide, wholesale used vehicle prices — the cars sold to other dealers — rose 1.7% from May through the first half of June, according to Cox Automotive's Manheim Used Vehicle Index.
The bottom line: Tariffs haven't warped the used car economy ... at least not yet.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
New car price inflation may already be here, and tariffs will make it worse: Cox Automotive
Analysts at Cox Automotive believe tariff-induced price hikes are coming for new cars — and could already be here. "The new vehicle market is likely to see the return of inflation, and it may already be happening," Cox senior economist Charlie Chesbrough said during the company's 2025 midyear review and second-half outlook. "Given the impact of tariffs, prices are likely to start rising at a much faster rate, so the trend suggests higher vehicle prices are coming to the new vehicle market," Chesbrough added. Chesbrough said the combination of higher-priced models affected by tariffs coming to replace depleted inventories, the declining use of incentives, and potential supply disruptions will create conditions that will shoot prices higher in the new car market. President Trump's auto sector tariffs began on April 3, but automakers had built up big buffers of non-tariffed supply before then. Supply is a big factor in pricing, and that non-tariff supply is dwindling. Cox data shows that in March, the industry's supply stood at 92 days. In June, that figure fell to 70, with some automakers like Toyota (TM) and Honda (HMC) having around half that amount. "The supply this year has been falling dramatically since March as the tariff-induced buying surge drew down available inventories," Chesbrough said. Read more: 6 steps to find cheap car insurance in 2025 Cox division Kelly Blue Book reports the average selling price of a new vehicle crept up to $48,799 in May, up from the month before but below the $50K mark seen in the height of the pandemic. As prices are poised to rise, sales may soon drop accordingly. May's sales pace fell to a seasonally adjusted annual rate of 15.6 million, Chesbrough said, with June slumping even further to 15.3 million, with more declines to follow. "The impact of tariffs have not been felt, and that will change in the 2nd half of this year," Chesbrough said. Chesbrough said the Cox team predicts that if tariffs remain in place, sales will fall around 1% to 2% to 15.7 million for the year, down from 15.9 million last year. The pain from falling sales won't hit all automakers uniformly. While GM (GM) performed well in the first half of the year, Cox predicts Toyota (TM) and Ford (FORD) could outperform in the second half, based on strong results in the second quarter. Stellantis (STLA), Volkswagen, and Tesla (TSLA) may suffer as they saw dropping sales and market share in the first half of the year. Pras Subramanian is the lead auto reporter for Yahoo Finance. You can follow him on X and on Instagram. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
11 hours ago
- Forbes
EV Sales On Verge Of Acceleration, Studies Predict
While sales of battery electric vehicles remain fairly sluggish, that is likely to change as ... More automakers introduce a greater portfolio of products at more affordable price points, studies predict. The sluggish sales rate for battery electric vehicles has turned EVs into the industry problem child. But new forecasts predict that while EV sales may still under-achieve automaker aspirations for some time, purely electric vehicles will find more buyers as a result of changing market dynamics, competition and product offerings. It's a prediction tough to divine when plowing through the latest sales trends. 'At the start of the year, we forecasted EVs would reach a 10% share of new vehicle sales by year end. But based on current trends, we now expect that number to land closer to 9%,' said Stephanie Valdez Streaty, director of industry insights at Cox Automotive during a webcast this week. She went on to say that while final numbers for Q2 aren't yet in, Cox is predicting EV sales for the three-month period will be down 6% from last year. Cox Automotive/Kelly Blue Book graph showing sales trends for electric vehicles. The prediction is almost as sobering from J.D. Power, which compared slumbering EV sales with those of hybrids. 'Hybrids are making waves again, setting a monthly record for June with a retail share of 14.1%, up 3.8 percentage points from a year ago. In contrast, EV share has dipped 1.9 percentage points, a notable shift from June 2024 when both technologies were even at 10.3%,' wrote Tyson Jominy, senior vice president of data and analytics at J.D. Power, in a report released Wednesday. Jominy chalked up the surge in hybrid sales on familiarity with technology that's been around for decades and dealers promoting high fuel economy leading to savings that could offset any price premium over internal combustion engine vehicles in less than two years. It all sounds pretty bad until you raise the gaze to a wider view. For one, many consumers rejecting EVs have done so because they were too expensive. That's changing. In May, the average transaction price, or ATP, for EVs fell to $57,734, down 2.3% from April and 1.1% from May, 2024, while average incentives rose to 14.2% of ATP in April, according to Cox. 'This downward trend highlights growing competition and pricing pressure across the EV segment,' noted Streaty. 'At the same time, EV incentives surged to 14.2% of ATP, the highest share in the modern EV era.' Cox Automotive/kelly Blue Book graph showing average transaction prices and incentives for battery ... More electric and electrified internal combustion engine vehicles. A key driver of lower EV transaction prices is discounting by EV market leader Tesla, which has seen its sales decline 15.2% in the first half of this year according to Cox data. Its ATP fell to $55,277, but that's still too rich for many consumers considering an EV. Hope for consumers, however, is not an empty emotion, as the industry's EV hierarchy is on the cusp of a major shuffling. 'While Tesla pulls back, GM is stepping up,' said Streaty. 'All three of their EV brands, Chevrolet, GMC, Cadillac, are showing strong momentum across the board. We're also seeing new players gain share, including Honda, Jeep and dodge. So while the overall market is softening, the story underneath the surface is one of redistribution.' That redistribution comes from a massive influx of new models, body styles and price points either in production or planned by automakers other than Tesla. Cox Automotive/Kelly Blue Book graphic showing growing EV body style and pricing choices. In 2020 EV shoppers had just 17 models from which to choose, split evenly between luxury and non-luxury. Today, that number has grown to 75 and luxury offerings have surged from seven to 39 models, while non-luxury options have expanded from 10 to 36, Cox data shows. 'EVs now are available across nearly every major vehicle segment. SUVs have seen the most dramatic expansion, and for the first time, trucks and vans are meaningfully represented in the EV space.' Things are looking up for greater EV choices on the used vehicle lots as well. Cox data shows about one million EVs have been leased since 2022. When those leases come due a surge of nearly new EVs will suddenly hit used vehicle lots according to Jeremy Robb, senior director of economic and industry insights at Cox. 'The mix of units coming back to the market will change dramatically when we get to 2027. EV lease maturities will comprise 16% of all volume, with plug-in hybrids being another 5% and the hybrid market being about 6% that means the traditional ICE market will only be about 72% of the total, and then we will have far greater diversification of units out there for used EV buyers,' Robb explained during this week's webcast. Not only are used EVs less expensive than new models, but their average price is about $2,000 less than used internal combustion engine vehicles, added Streaty. The bottom line, she notes, is consumers who had been holding off making the plunge into battery-powered mobility, may soon find some of their key reasons for doing so are evaporating, declaring, 'More consumers than ever can now find an EV that fits their lifestyle budget and brand preference.'
Yahoo
16 hours ago
- Yahoo
Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target
Inventiva S.A. (NASDAQ:IVA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. Analyst Edward Nash from Canaccord Genuity maintained a Buy rating on Inventiva S.A. (NASDAQ:IVA) on June 5, keeping the price target at $20.00. The rating was based on several factors, including the potential of lanifibranor, the company's lead asset in the MASH space. Lanifibranor's oral administration and direct anti-fibrotic effects distinguish it from other treatments in development, with a primary focus on liver fat reduction. A research scientist in an idiopathic pulmonary fibrosis laboratory, carrying out clinical trials. The analyst also reasoned that Lanifibranor can be used in conjunction with other treatments, including GLP-1s and SGLT2 inhibitors. This factor is a significant boost to its appeal, especially when considering the high prevalence of type 2 diabetes in MASH patients. Nash stated that the drug is progressing well, which can be corroborated by the completion of full enrollment in the Phase III NATiV3 trial and the anticipated top-line data in H2 2026. Major pharmaceutical companies are also showing increasing interest in the MASH space, further supporting the optimistic outlook for Inventiva S.A. (NASDAQ:IVA). Inventiva S.A. (NASDAQ:IVA) is a clinical-stage biopharmaceutical company that develops oral small-molecule therapies to treat non-alcoholic steatohepatitis or NASH. It also develops therapies for other diseases with considerable unmet medical needs. While we acknowledge the potential of IVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
